v3.26.3
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash, cash equivalents and current restricted cash $ 390,220 $ 369,074
Accounts receivable, net 80,214 90,255
Inventory, net 50,601 52,733
Other current assets and prepaid expenses 37,183 56,729
Current assets held for sale 248,060 13,090
Total current assets 806,278 581,881
Property, plant and equipment, net 68,023 72,815
Intangible assets, net 396,168 446,428
In-process research and development 195,000 195,000
Goodwill 317,364 320,846
Investments 44,499 14,168
Operating lease right-of-use assets 33,883 37,153
Other assets 19,035 19,139
Noncurrent assets held for sale 0 244,513
Total assets 1,880,250 1,931,943
Current liabilities:    
Accounts payable 47,917 41,103
Accrued expenses 84,081 84,406
Current maturities of operating leases 7,791 7,603
Current portion of lines of credit and notes payable 13,149 10,251
Current liabilities held for sale 9,418 3,314
Total current liabilities 162,356 146,677
Operating lease liabilities 26,840 30,083
Long term portion of convertible notes 92,458 85,020
Senior secured royalty financing 370,225 246,433
Deferred tax liabilities 96,674 126,241
Other long-term liabilities 15,523 22,798
Noncurrent liabilities held for sale 0 6,732
Total long-term liabilities 601,720 517,307
Total liabilities 764,076 663,984
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 742,506,477 and 789,917,433 shares issued at September 30, 2026 and December 31, 2025, respectively 7,426 7,900
Treasury Stock - 30,849,907 shares at December 31, 2025 0 (3,176)
Additional paid-in capital 3,549,531 3,574,942
Accumulated other comprehensive loss (33,295) (21,017)
Accumulated deficit (2,407,488) (2,290,690)
Total shareholders’ equity 1,116,174 1,267,959
Total liabilities and equity $ 1,880,250 $ 1,931,943

Source

10-QHTML XBRL Zip